loading... download flash
spacer spacer spacer spacer spacer
 
 
Snapshot

Revenue & Earnings
Revenue (mil)(FYE) 82.82
Income From Continuing Operations (mil)(FYE) -181.01
Income From Total Operations (mil)(FYE) -181.01
Diluted EPS From Continuing Operations (FYE) -3.05
Diluted EPS From Total Operations (FYE) -3.05
Dividends
Ex-Dividend Date
Dividend Rate .00
Yield .00%
Yield - 5 Year Average .00
Ratios
Price To Revenue 5.75
Price To Cash Flow -8.53
Price to Book -2.99
Debt To Equity -215.48
Current Ratio 5.51
Growth Rates
5-Year Annual Dividend Growth Rate .00
5-Year Annual Revenue Growth Rate 73.38
Printer Friendly Page
spacer
spacer
spacer spacer
Back to Top
footer header
Home | About CVT | Media | Investors | Careers | Terms of Use | Privacy Policy | Contact Us | Site Map | webmaster@cvt.com
© 1999-2008, CV Therapeutics, Inc. All rights reserved.
 
spacer
Please Note: The websites of CV Therapeutics, Inc. are not intended to provide medical advice,
nor is any information here a substitute for professional healthcare. Consult your doctor or other
healthcare provider for information about your diagnosis, treatment, or condition.